Additionally, astrocyte activity and CNS inflammation are modulated by type I interferons and tryptophan metabolites via the aryl hydrocarbon receptor, and administration of an aryl hydrocarbon receptor agonist can attenuate intestinal inflammation in mouse models of colitis ([21, 22]). This evidence concerns the gene AHR and colitis.